• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(丙交酯-共-乙交酯)微球中疏水分子的组合共包封。

Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.

机构信息

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611-6131, USA.

出版信息

Biomaterials. 2013 Apr;34(13):3422-30. doi: 10.1016/j.biomaterials.2013.01.032. Epub 2013 Feb 1.

DOI:10.1016/j.biomaterials.2013.01.032
PMID:23375950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3605192/
Abstract

There is great interest for developing poly(lactide-co-glycolide) (PLGA) based particles for targeted delivery and controlled release of encapsulated biological molecules. These PLGA particles can be used to deliver proteins, small molecule drugs and nucleotides. Furthermore, it has been shown that the co-encapsulation of multiple factors in PLGA particles can generate synergistic responses, and can also provide theranostic capability. However, the number of possible unique particle formulations that may be generated by the combination of different components in a particle increases dramatically with each new component, and currently, there is no method to generate large libraries of unique PLGA particles. In order to address this gap, we have developed a high-throughput methodology to produce hundreds of small batches of particles. The particles are generated in multi-well plate wells by a modified oil-in-water emulsion technique. In order to demonstrate the versatility of this technique, combinatorial formulations of six different loading concentrations of three fluorescent dyes were fabricated giving rise to 216 unique PLGA particle formulations. We demonstrate systematic and well-controlled combinatorial loading of hydrophobic molecules into the particles. This parallel particle production (PPP) methodology potentiates the generation of hundreds of different combinatorial particle formulations with multiple co-encapsulates in less than 24 h in standard polystyrene multi-well plates, thus providing rapid, low cost, high-throughput production. We envision that such a PPP library of particles encapsulating combinations of drugs and imaging modalities can subsequently be tested on small populations of cells in a high-throughput fashion, and represents a step toward personalized medicine.

摘要

人们对于开发聚(丙交酯-共-乙交酯)(PLGA)基颗粒以实现封装生物分子的靶向递送和控制释放非常感兴趣。这些 PLGA 颗粒可用于递送蛋白质、小分子药物和核苷酸。此外,已经表明,在 PLGA 颗粒中共同封装多种因子可以产生协同反应,并且还可以提供治疗诊断能力。然而,通过在颗粒中组合不同成分可能产生的独特颗粒制剂的数量随着每个新成分的增加而急剧增加,并且目前,没有方法可以生成大量独特的 PLGA 颗粒库。为了解决这一差距,我们开发了一种高通量方法来生产数百批小批量的颗粒。这些颗粒通过改良的油包水乳液技术在多孔板孔中生成。为了证明该技术的多功能性,我们制备了六种不同加载浓度的三种荧光染料的组合配方,产生了 216 种独特的 PLGA 颗粒制剂。我们证明了疏水分子系统地和受控地装载到颗粒中。这种并行颗粒生产(PPP)方法可以在不到 24 小时的时间内在标准聚苯乙烯多孔板中生成数百种不同的组合颗粒制剂,并且具有多个共封装物,从而提供快速、低成本、高通量的生产。我们设想,这样一个封装了药物和成像模式组合的 PPP 颗粒文库可以随后以高通量的方式在小群体的细胞上进行测试,这是迈向个性化医疗的一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/097fffb04927/nihms442004f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/63b7dd3eb357/nihms442004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/7131b497b1d9/nihms442004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/5397c803594d/nihms442004f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/36a578d58860/nihms442004f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/505f26aafe02/nihms442004f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/097fffb04927/nihms442004f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/63b7dd3eb357/nihms442004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/7131b497b1d9/nihms442004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/5397c803594d/nihms442004f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/36a578d58860/nihms442004f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/505f26aafe02/nihms442004f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52aa/3605192/097fffb04927/nihms442004f6.jpg

相似文献

1
Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.聚(丙交酯-共-乙交酯)微球中疏水分子的组合共包封。
Biomaterials. 2013 Apr;34(13):3422-30. doi: 10.1016/j.biomaterials.2013.01.032. Epub 2013 Feb 1.
2
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.蛋白质从聚(丙交酯-共-乙交酯)微球中的包封与释放:蛋白质和聚合物性质以及表面活性剂共包封的影响
Eur J Pharm Biopharm. 1998 May;45(3):285-94. doi: 10.1016/s0939-6411(98)00011-3.
3
One-step surface modification of poly(lactide-co-glycolide) microparticles with heparin.聚(丙交酯-乙交酯)微粒与肝素的一步法表面改性
Pharm Res. 2007 Dec;24(12):2381-93. doi: 10.1007/s11095-007-9378-1. Epub 2007 Aug 21.
4
Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.聚乳酸-乙醇酸共聚物(PLGA)中丙交酯和乙交酯的不同比例会影响添加疏水性添加剂的PLGA微球的表面性质和蛋白质递送特性。
J Microencapsul. 2006 Feb;23(1):15-27. doi: 10.1080/02652040500286110.
5
Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.新型水包油包亲水性油包水乳液法制备 PLGA 微球及其缓释性能研究。
Int J Nanomedicine. 2013;8:2433-41. doi: 10.2147/IJN.S45186. Epub 2013 Jul 8.
6
Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.不同非离子表面活性剂共包封对载胰岛素聚乳酸-羟基乙酸共聚物微球性质的影响
J Control Release. 2000 Nov 3;69(2):283-95. doi: 10.1016/s0168-3659(00)00315-1.
7
Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.制剂参数对含聚(L-赖氨酸)复合质粒DNA的聚(D,L-丙交酯-共-乙交酯)微球特性的影响。
J Control Release. 1999 Aug 5;60(2-3):279-86. doi: 10.1016/s0168-3659(99)00076-0.
8
Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.通过纳米晶体和水溶性聚合物模板技术提高灯盏花素在聚乳酸-羟基乙酸共聚物微粒中的包封率和生物利用度。
Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2.
9
Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.用于蛋白质递送的聚乳酸-羟基乙酸共聚物与聚(丙烯酰羟乙基淀粉)复合微球系统的制备与表征
Pharm Res. 2001 Nov;18(11):1600-6. doi: 10.1023/a:1013090700443.
10
Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.材料疏水性对双乳液法制备的聚合物微球物理性质的影响。
J Control Release. 2002 Dec 5;84(3):151-60. doi: 10.1016/s0168-3659(02)00292-4.

引用本文的文献

1
Immunosuppressive Formulations for Immunological Defense against Traumatic Brain Injury.用于创伤性脑损伤免疫防御的免疫抑制制剂。
Adv Healthc Mater. 2025 Jul;14(19):e2501417. doi: 10.1002/adhm.202501417. Epub 2025 May 29.
2
Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro-Inflammatory Macrophage Activation.用于细胞内调节促炎性巨噬细胞活化的衣康酸聚合物微粒的研发
Adv Healthc Mater. 2025 May;14(13):e2405257. doi: 10.1002/adhm.202405257. Epub 2025 Apr 4.
3
Alpha-ketoglutaric acid based polymeric particles for cutaneous wound healing.基于α-酮戊二酸的聚合物粒子在皮肤创伤愈合中的应用。
J Biomed Mater Res A. 2023 Sep;111(9):1372-1378. doi: 10.1002/jbm.a.37539. Epub 2023 Mar 23.
4
Biomaterial mediated simultaneous delivery of spermine and alpha ketoglutarate modulate metabolism and innate immune cell phenotype in sepsis mouse models.生物材料介导的腐胺和α-酮戊二酸的同时递送调节脓毒症小鼠模型中的代谢和固有免疫细胞表型。
Biomaterials. 2023 Feb;293:121973. doi: 10.1016/j.biomaterials.2022.121973. Epub 2022 Dec 17.
5
The effect of different surface treatment methods on the physical, chemical and biological performances of a PGA scaffold.不同表面处理方法对聚乙醇酸支架物理、化学和生物学性能的影响。
RSC Adv. 2019 Jun 28;9(35):20174-20184. doi: 10.1039/c9ra02100k. eCollection 2019 Jun 25.
6
Inhibition of glycolysis in the presence of antigen generates suppressive antigen-specific responses and restrains rheumatoid arthritis in mice.在抗原存在的情况下抑制糖酵解会产生抑制性的抗原特异性反应,并抑制小鼠的类风湿性关节炎。
Biomaterials. 2021 Oct;277:121079. doi: 10.1016/j.biomaterials.2021.121079. Epub 2021 Aug 20.
7
GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations.GRAS 微粒微阵列鉴定树突状细胞耐受原性标记诱导制剂。
Lab Chip. 2021 Sep 14;21(18):3598-3613. doi: 10.1039/d1lc00096a.
8
Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4 or CD8 T cell activation.聚(2-丙基丙烯酸)/聚(乳酸-乙醇酸)共混微粒作为一种靶向抗原递送系统,用于直接激活CD4或CD8 T细胞。
Bioeng Transl Med. 2017 Jul 11;2(2):202-211. doi: 10.1002/btm2.10068. eCollection 2017 Jun.
9
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.涉及炎症的非感染性眼病的现代治疗方法
Adv Healthc Mater. 2017 Dec;6(23). doi: 10.1002/adhm.201700733. Epub 2017 Oct 16.
10
Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.采用生物活性聚合物(醋酸菊粉)设计的病原体模拟疫苗递送系统,可引发强大的体液免疫和细胞免疫反应。
J Control Release. 2017 Sep 10;261:263-274. doi: 10.1016/j.jconrel.2017.06.026. Epub 2017 Jun 29.

本文引用的文献

1
Combinatorial Synthesis of and high-throughput protein release from polymer film and nanoparticle libraries.聚合物薄膜和纳米颗粒文库的组合合成及高通量蛋白质释放
J Vis Exp. 2012 Sep 6(67):3882. doi: 10.3791/3882.
2
Microparticle surface modifications targeting dendritic cells for non-activating applications.针对树突状细胞的非激活应用的微粒表面修饰。
Biomaterials. 2012 Oct;33(29):7221-32. doi: 10.1016/j.biomaterials.2012.06.049. Epub 2012 Jul 12.
3
PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors.用于超声介导基因递送至实体瘤的聚乳酸-羟基乙酸共聚物纳米颗粒
J Drug Deliv. 2012;2012:767839. doi: 10.1155/2012/767839. Epub 2012 Feb 28.
4
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.用纳米颗粒 PLGA 癌症疫苗制剂靶向树突状细胞。
Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):943-55. doi: 10.1016/j.addr.2011.05.021. Epub 2011 Jun 6.
5
Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.多功能靶向树突状细胞的聚合物微粒:用于1型糖尿病的新型疫苗研发
Hum Vaccin. 2011 Jan 1;7(1):37-44. doi: 10.4161/hv.7.1.12916.
6
Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells.黏附底物调节非肥胖型糖尿病小鼠来源树突状细胞的激活和刺激能力。
Acta Biomater. 2011 Jan;7(1):180-92. doi: 10.1016/j.actbio.2010.08.026. Epub 2010 Aug 31.
7
The modulation of dendritic cell integrin binding and activation by RGD-peptide density gradient substrates.通过 RGD 肽密度梯度底物调节树突状细胞整合素结合和激活。
Biomaterials. 2010 Oct;31(29):7444-54. doi: 10.1016/j.biomaterials.2010.06.025. Epub 2010 Jul 16.
8
Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection.生物材料佐剂效应可通过抗炎药物递送或材料选择来减弱。
J Control Release. 2010 Sep 15;146(3):341-8. doi: 10.1016/j.jconrel.2010.05.032. Epub 2010 Jun 2.
9
Intravital microscopy imaging of macrophage localization to immunogenic particles and co-localized tissue oxygen saturation.免疫原性颗粒定位的活体显微镜成像和共定位组织氧饱和度。
Acta Biomater. 2010 Sep;6(9):3491-8. doi: 10.1016/j.actbio.2010.03.006. Epub 2010 Mar 11.
10
Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype.验证一种高通量方法,以评估生物材料对树突状细胞表型的影响。
Acta Biomater. 2010 Jul;6(7):2621-30. doi: 10.1016/j.actbio.2010.01.023. Epub 2010 Jan 22.